Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    What Firms Should Do to Best Prepare for and Manage Audits by EU Notified Body and FDA

    View: 219

    Website https://compliance2go.com/product/?pid=CP2014-430 | Want to Edit it Edit Freely

    Category Pharmaceutical

    Deadline: March 31, 2015 | Date: March 31, 2015

    Venue/Country: Online, U.S.A

    Updated: 2015-03-03 18:04:22 (GMT+9)

    Call For Papers - CFP

    DESCRIPTION

    This webinar is intended to help you get familiar with regulatory audits by the US Food and Drug Administration and EU Notified Bodies.

    This webinar is further intended to help you understand what you can do to best prepare for and manage the audits by EU Notified Bodies and FDA with increased awareness.

    The FDA enforcement actions have recently increased. In EU, EU commission issued recommendation concerning unannounced audits by notified bodies in medical device industry.

    As a medical device firm, you are subject to regulatory audits or inspection by the US FDA and EU notified body if you bring your medical device products into the US and EU countries allowing CE-marked products.

    This webinar will cover the details of how you can proactively prepare for and manage the audits.

    Why Should you Attend

    To learn how to adequately prepare for and manage regulatory audits by the US FDA and EU notified bodies.

    Areas Covered in the Webinar

    Statutes and Regulations in US and EU

    Definitions

    EU Unannounced Audits

    Comparative Overview of both ISO 13485 and 21 CFR Part 820

    Understanding Auditing Strategy

    Audit Objectives and Process

    How to Audit Quality Management Systems

    Various Audit Approaches

    Quality Systems and Subsystems in ISO 13485

    Quality Systems and Subsystems under 21 CFR Part 820

    FDA and ISO 13485

    Communication during Audit or Inspection: Dos and Don’ts

    Good Practices: Speaker’s Suggestions and Recommendations

    Conclusion

    Who will Benefit

    Regulatory Affairs

    Quality Professionals

    R&D

    Complaint And Risk Management Personnel

    Consultants

    Contractors/Subcontractors

    CEOs

    VPs

    Clinical Affairs

    Other Interested Parties

    Webinar Includes:

    Q/A Session with the Expert to ask your question

    Copy of PowerPoint slides (PDF print only)

    60 Minutes Live Presentation

    Certificate of Attendance


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.